American Journal of Clinical Dermatology

, Volume 18, Issue 4, pp 595–596 | Cite as

Author’s Reply to Cohen: Facial Hyperpigmentation in Skin of Color: Special Considerations and Treatment

  • Neelam A. Vashi
  • Mayra B. C. Maymone
  • Roopal V. Kundu
Letter to the Editor


  1. 1.
    Cohen PR. Comment on: facial hyperpigmentation in skin of color: special considerations and treatment. Am J Clin Dermatol. 2017. doi:10.1007/s40257-017-0303-z.
  2. 2.
    Jang YH, Lee JY, Kang HY, Lee ES, Kim YC. Oestrogen and progesterone receptor expression in melasma: an immunohistochemical analysis. J Eur Acad Dermatol. 2010;24:1312–6.CrossRefGoogle Scholar
  3. 3.
    Lee AY. Recent progress in melasma pathogenesis. Pigment Cell Melanoma Res. 2015;28(6):648–60.CrossRefPubMedGoogle Scholar
  4. 4.
    Kim EH, Kim YC, Lee ES, Kang HY. The vascular characteristics of melasma. J Dermatol Sci. 2007;46:111–6.CrossRefPubMedGoogle Scholar
  5. 5.
    Know SH, Hwang YJ, Lee SK, Park KC. Heterogeneous pathology of melasma and its clinical implications. Int J Mol Sci. 2016;17:E824.CrossRefGoogle Scholar
  6. 6.
    Na JI, Choi SY, Yang SH, Choi HR, Park KC. Effect of tranexamic acid on melasma: a clinical trial with histological evaluation. J Eur Acad Dermatol Venereol. 2013;27(8):1035–9.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  • Neelam A. Vashi
    • 1
  • Mayra B. C. Maymone
    • 1
  • Roopal V. Kundu
    • 2
  1. 1.Department of DermatologyBoston University School of MedicineBostonUSA
  2. 2.Department of DermatologyNorthwestern University Feinberg School of MedicineChicagoUSA

Personalised recommendations